BLAC (Bellevue Life Sciences Acquisition) Change In Receivables : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bellevue Life Sciences Acquisition Change In Receivables?

Bellevue Life Sciences Acquisition's change in receivables for the quarter that ended in Sep. 2024 was $0.00 Mil. It means Bellevue Life Sciences Acquisition's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Bellevue Life Sciences Acquisition's change in receivables for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Bellevue Life Sciences Acquisition's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Bellevue Life Sciences Acquisition's Accounts Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bellevue Life Sciences Acquisition's liquidation value for the three months ended in Sep. 2024 was $-6.00 Mil.

Bellevue Life Sciences Acquisition Change In Receivables Historical Data

The historical data trend for Bellevue Life Sciences Acquisition's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bellevue Life Sciences Acquisition Change In Receivables Chart

Bellevue Life Sciences Acquisition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Bellevue Life Sciences Acquisition Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial									-	-	-	-	-

Bellevue Life Sciences Acquisition Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Bellevue Life Sciences Acquisition (NAS:BLAC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bellevue Life Sciences Acquisition's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Bellevue Life Sciences Acquisition's accounts receivable are only considered to be worth 75% of book value:

Bellevue Life Sciences Acquisition's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.012	-	6.011	+	0.75 * 0	+	0.5 * 0
=	-6.00

Bellevue Life Sciences Acquisition Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bellevue Life Sciences Acquisition's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bellevue Life Sciences Acquisition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Bellevue Life Sciences Acquisition Corp (NAS:BLAC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

10900 NE 4th Street, Suite 2300, Bellevue, WA, USA, 98004

Website

https://www.bellevuespac.com

Bellevue Life Sciences Acquisition Corp is a blank check company.

Executives

David Jin Yoo	officer: Chief Financial Officer	(135-270) 7TH FLOOR, SOFTFORUM B/D., 545-7 DOGOKDONG, GANGNAM, SEOUL M5 135-170
Kuk Hyoun Hwang	director, 10 percent owner, officer: Chief Executive Officer	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Bellevue Global Life Science Investors Llc	10 percent owner	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Steven Reed	other: Director Nominee	2843-122 PL. N.E., BELLEVUE WA 98005
In Chul Chung	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Hosun Euh	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jin Whan Park	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jun Chul Whang	director	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Rad Roberts	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004